Institute of Animal Technology Congress 1999
Wednesday-Saturday 3-6 March 1999 (Cyprus) The unusual venue for the Congress has been forced on the IAT because of the difficulty in finding suitable venues in the UK which have the required security. Last year's successful Congress in Jersey has shown that overseas venues are not a bar to holding a successful meeting, providing the costs are low. This is certainly the case here and the Congress Committee have negotiated a very attractive all-inclusive cost which is comparable to that of a UK meeting. As usual, there will be platform sessions, workshops, posters [with brief oral presentation) and keynote speakers and of course, the incomparable trade exhibition. The five-star Conference Centre has rooms for 10 to 700 people and the latest audio-visual equipment. Passports will be required but not visas or vaccinations. For registration and further details contact Alan Graham, Department of Physiology} University of Cambridge, Downing Street, Cambridge CB2 3EG, UK.
29th Annual Symposium of the Scandinavian Society for Laboratory Animal Science (Scand-LAS)
Thursday-Sunday 6-9 May 1999 (Aland, Finland) The theme of the meeting is Science and Responsibility and the main topics will include Evaluation of the quality of laboratories and test systems using animals; Toxicology in vivo and in vitro; Animal rights and human rights; Practical suggestions for animal technicians on gene-manipulated animals; Primates; Animal transport and delivery; Safety in working with laboratory animals. Sunday-Thursday 29 August-2 September 1999 (Bologna, Italy) The aim of the Congress will be to promote the exchange of information on the application of alternatives} specifically the 3Rs of Russell and Burch, to laboratory animal procedures. The programme will include plenary lectures, parallel platform sessions, workshops, point/counterpoint discussions, poster sessions and video demonstrations. There will be five parallel themes: the development of replacement alternative methods; the validation and regulatory acceptance of alternative methods; reduction and immunobiologicals; refinement; education, ethics and databases. Some examples of the 15 workshops scheduled are training in reduction strategies; improving communication between statisticians and research scientists; good laboratory practices and ISO 9000) adjuvants: do we want to escape from the use of Freund's1; vaccines without using laboratory a nimals; pain and distress; emichment: housing and husbandry; rationalizing systemic acute toxicity testing in vivo and replacing it with non· animal strategiesj refinement: scientific society guidelines; cats and dogs as experimental animals: do they deserve special consideration 1; animal rights and human rights: harmony or conflict1 There will be a full social programme. For registration and full programme information contact: FRAME, 96-98 North Sherwood Street, Nottingham NGI 4EE, UK. Tel: ++44(01115 958 4740. Fax: ++44 (0) 
ticals. Harlow/18!une 1998
Both section convenors would like to express their gratitude to Smithkline Beecham for hosting the meeting and for their generous sponsorship towards it.
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Practical Implications of Transgenesis on a Laboratory Animal Science Resource
Rick Carver, National Institute for Medical Research The impact on the following areas of operation were discussed: competence, personnel, facilities, animals, legislative, and management. Also discussed were why transgenic strains of mice are so special and the various ways of protecting them from inadvertent contamination by potential pathogens. Plans to cope with contingencies should be drafted from the outset, including disaster planning by having cryopreserved embryos/sperm or back-up breeding colonies at dual locations.
Health Monitoring Strategies
Patrick Hardy, Charles River, [fla Credo In the commercial situation the adage 'Never trust anyone and check everything' is adopted towards health monitoring of customers' strains on receipt at their breeding facility. Animals are isolated on receipt until their health status has been determined. TG strains tend to contain a wide range of potential pathogens because of extensive sourcing from academic facilities. The pathogens most frequently isolated include: MHV, MVM, sendai, mycoplasma, pasteureallae and more recently lymphocytic choriomeningitis virus which has zoonotic implications. Patrick stated that the collective health status of TG strains is worsening reflecting their increasing transportation world-wide.
All animals at Iffa Credo are bred in filter topped cages (FTCs) reflecting the need for good containment plus operational flexibility. Rarely do FTCs breakdown, thereby justifying their use versus full isolators. Faecal samples from stock cages are checked for opportunists monthly to assess microbiological security. If any of the bacteria Proteus spp., Staphylococcus spp. or pseudomonads are detected then the animals are given a full screen. Breeding cages are checked using ex-breeders monthly on a limited screen for viruses and bacteria and 3 monthly according to the FELASA recommendations.
Genetic Monitoring of Transgenic Strains
Adrian Deeny, Harlan UK Genetic monitoring is the assurance of noncompromise. Various types of screening strategies were discussed: coat colour, traits (hypertensionJ, mandible morphology, immunology, skin grafting, biochemical markers, DNA finger printing (RFLPs), and by PCR marker. Recent work has been published demonstrating the effectiveness of using DNA from saliva for screening mice thereby reducing the need for more invasive sampling techniques. Apparently there is insufficient yield of salivary DNA from recently weaned animals but that is likely to change as detection methods become more sensitive.
Other screens need to consider the age of onset of the characteristic, e.g. maturation of CD4 or CD8 lymphocytes. Test breeding of chimeras can be performed to attempt separation of those with ES cell derived gametes from host gametes.
Finally definite separation criteria should be adopted for breeding animals of different strains to ensure interbreeding of strains does not occur.
Selection of Suitable Mouse Strains for Transgenesis
Kathleen Mathers, National Institute for Medical Research Factors to consider in the selection of mouse strains include strain variations in superovulation rates, ability to culture embryos, post injection survival and pronuclear visibility when used as embryo donors. C57/BL6 and FVB strains seem best. rCR and Fl hybrid mice are best suited as embryo recipients due to their, respectively, large ampullae and good mothering characteristics. One hundred and twenty-nine strain mice are invariably used for gene targeting however it has recently been shown that sub-strain differences exist therefore the researcher is advised to use 129 strain mice purchased from the same source throughout.
Decision Points in the Procurement of Individually Ventilated Cage Systems
Ron Raymond. Imperial Cancer Research Fund The talk centred on his experiences in setting up their transgenic facility at ICRF, leading the audience through their decision process. Items he considered included:
(1) Use of HEPA filtration on inlet and/or exhaust ventilation ports.
(2) The need to autoclave cages prior to re-use. (31Types of colour-coded system to ensure separation of operations for differing TG colonies. 14)Time to service and conduct husbandry procedures within rvcs as compared to flexible 6.lm isolators.
151 How frequently should cage bedding be changed.
It was mentioned that the damage to polycarbonate cages following repeated autoclaving was due to resins from the sawdust being autoclaved in the cages. A publication is expected soon. Use of Alphadry, a paper-based bedding material instead may alleviate this problem.
Transgenic Animal Welfare Roger Francis, Bristol University, UK Mr Francis compared three TG strains reared at Bristol with some inbred mouse strains of varying reproductive performance. Various righting reflexes were assessed and no particular differences were noted with the exception of one TG strain which was prone to ataxia. The welfare implications of procedural issues were discussed notably tail tipping, transponder implantation, husbandry issues of colony rederivation, superovulation and the overall competence of the animal care staff.
Notes and comments
The speaker was adamant that in an academic facility trained animal technicians should be responsible for the day-to-day care and husbandry as opposed to scientists and research assistants whom he considered generally lacking in husbandry experience and insufficiently attuned to the animals' needs and welfare.
Announcement
ESLAV, ECLAM, and FELASA
The European Society of Laboratory Animal Veterinarians (ESLAVIwas created at the 6th FELASA symposium held in June 1996 in Basel, Switzerland. The Society is now registered as a non-profit organization in France (http://www:eslav.org). A main objective of the Society is to provide a forum for European veterinarians to discuss issues which concern them in the field of laboratory animal medicine and science, and to pool resources where appropriate. ESLAV will be able to specifically represent this specialty within the veterinary profession in general and to European decisionmaking bodies, and to become a contact point for other organizations.
Another important objective of this Society is the facilitation of the creation of the European College of Laboratory Animal Medicine (ECLAM; http://www:eclam.org).This will be a veterinary specialist college subject to regulation by the European Board of Veterinary Specialization IEBVS1. Its function will be focused on providing certification and training, to the standards of other European veterinary specialist colleges, in the field of Laboratory Animal Medicine. A small steering group has recently met with EBVS,who have given approval for starting the process of creation of an ECLAM. ECLAM would be formally independent from ESLAV,but will work closely with ESLAVand with Laboratory Animal Science Organizations.
The first general assembly of ESLAVwill be held at the 7th FELASA symposium in Mallorca in May 1999. One of the goals of ESLAVis the close collaboration with other organizations, in particular FELASA (http://www.fe1asa.org) and its constituents. Contacts with the FELASABoard have already been established, including a presentation of ESLAV and ECLAM to the FELASA Board and a first discussion about the future collaboration to be developed between each Association. No final decision about the specific roles and missions of FELASA and ESLAVhas been reached yet but both Associations clearly expressed their will to operate in synergy and avoid duplication of interests and roles. Further discussions are planned.
Philippe Baneux President, ESLAV
Tim Morris
Coordinator, steering group for proposed ECLAM Patrick Hardy President, FELASA
